Medtronic announced Friday that FDA has approved the the first MR-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure in the U.S. The Medtronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results